← Leaderboards
Robin J Shattock
Imperial College Of Science, Technology And Medicine
$2,227,977
Attributed
$2,919,581
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $348.6K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,919,581 · 6
By mechanism
R01$1,030,794 · 1
U19$867,702 · 2
R21$593,414 · 2
UM1$427,671 · 1
Top collaborators
- Shiranee Sriskandan3 shared
- Carolina Herrera2 shared
Most similar at Imperial College Of Science, Technology And Medicine
Same institution · by research overlap
- Shiranee Sriskandan$515,397
- Carolina Herrera$176,207
Others in their field
Top investigators on “Series”
- Lawrence Corey · Fred Hutchinson Cancer Center$445,660,381
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- David R. Weir · University Of Michigan At Ann Arbor$276,156,779
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$231,733,045
- Dennis R. Burton · Scripps Research Institute$199,946,411
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
Research focus
SeriesInfectionPreventIn VivoFutureInvestigationPathogenVaginaResponseTechnologyTissuesViralHiv-1CervicalInhibitor/AntagonistCellsEventResearch StudyPhysiologicalMucous MembraneProgramsBaseMacaca MulattaClinical Trials
Grant awards (16)
An RNA vaccines systems approach to Group A streptococcus vaccine discovery$345,037
R01 · FY2025 · AI
An RNA vaccines systems approach to Group A streptococcus vaccine discovery$344,112
R01 · FY2024 · AI
An RNA vaccines systems approach to Group A streptococcus vaccine discovery$341,645
R01 · FY2023 · AI
Mucosal biology scientific research support component$251,421
UM1 · FY2013 · AI · contact PI
Mucosal biology scientific research support component$176,250
UM1 · FY2012 · AI · contact PI
Mucosal tissue explants as surrogates for in vivo efficacy of microbicides$172,346
R21 · FY2012 · AI
Mucosal tissue explants as surrogates for in vivo efficacy of microbicides$180,068
R21 · FY2011 · AI
Characterization of entry inhibitors in human cervical & rectal tissue models & d$34,844
U19 · FY2011 · AI · contact PI
Characterization of entry inhibitors in human cervical & rectal tissue models & d$41,485
U19 · FY2010 · AI · contact PI
Characterization of entry inhibitors in human cervical & rectal tissue models & d$34,568
U19 · FY2009 · AI · contact PI
Characterization of entry inhibitors in human cervical & rectal tissue models & d$44,820
U19 · FY2008 · AI · contact PI
Attachment, Fusion & Entry (AFE)Inhibitors in human cervical & rectal tissue$248,886
U19 · FY2007 · AI · contact PI
CHARACTERIZATION OF AFE INHIBITORS IN HUMAN CERVICAL/REC$233,199
U19 · FY2006 · AI · contact PI
CHARACTERIZATION OF AFE INHIBITORS IN HUMAN CERVICAL/REC$229,900
U19 · FY2005 · AI
HIV infection of male genital tissue (R21)$108,000
R21 · FY2005 · HD
HIV infection of male genital tissue$133,000
R21 · FY2004 · HD